Literature DB >> 24568482

Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC.

Chuan Xu1, Peng-Hua Lv, Xin-En Huang, Shu-Xiang Wang, Ling Sun, Fu-An Wang, Li-Fu Wang.   

Abstract

OBJECTIVE: To evaluate the safety and efficacy of sequential transcatheter arterial chemoembolization (TACE )and portal vein embolization (PVE) before major hepatectomy for patients with hepatocellur carcinoma (HCC).
METHODS: In this retrospective case-control study, data were collected from patients who underwent sequential TACE and PVE prior to major hemihepactectomy. Liver volumes were measured by computed tomography volumetry before TACE, and preoperation to assess degree of future remnant liver (FRL) hypertrophy and to check whether intro- or extrohepatic metastasis existed. Liver function was monitored by biochemistry after TACE, prior to and after major hepatectomy.
RESULTS: Mean average FRL volume increased 32.3-71.4% (mean 55.4%) compared with preoperative FRL volume. After TACE, liver enzymes were elevated, but returned to normal in four weeks. During PVE and resection, no patient had intro- or extrohepatic metastasis.
CONCLUSION: Sequential TACE and PVE is an effective method to improve resection opportunity, expand the scope of surgical resection, and greatly reduce postoperative intra- and extrahepatic metastasis.

Entities:  

Mesh:

Year:  2014        PMID: 24568482     DOI: 10.7314/apjcp.2014.15.2.703

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

Review 1.  Strategies to increase the resectability of hepatocellular carcinoma.

Authors:  Wong Hoi She; Kenneth Sh Chok
Journal:  World J Hepatol       Date:  2015-08-28

2.  Liver Injury and Tumor-Inhibiting Effect of Sequential Transcatheter Arterial Chemoembolization and Portal Venous Embolization on Rabbit VX2 Liver Carcinoma.

Authors:  Dongda Song; Minggen Hu; Weichang Guo
Journal:  Med Sci Monit       Date:  2017-03-27

3.  In situ splitting after selective partial portal vein ligation or simultaneous hepatic artery ligation promotes liver regeneration.

Authors:  Li-Bin Yao; Chong-Hui Li; Xiao-Juan Wu; Xue-Dong Wang; Xin-Lan Ge; Ai-Qun Zhang; Xiao-Cheng Zhu; Yong Shao; Jia-Hong Dong
Journal:  Sci Rep       Date:  2018-06-07       Impact factor: 4.379

4.  Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?

Authors:  Ze-Feng Zhang; Yu-Jun Luo; Quan Lu; Shi-Xue Dai; Wei-Hong Sha
Journal:  World J Clin Cases       Date:  2018-09-06       Impact factor: 1.337

5.  Selective occlusion of the hepatic artery and portal vein improves liver hypertrophy for staged hepatectomy.

Authors:  Changku Jia; Ke Ge; Sunbing Xu; Ling Liu; Jie Weng; Youke Chen
Journal:  World J Surg Oncol       Date:  2019-10-07       Impact factor: 2.754

Review 6.  Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review.

Authors:  Zhiying Shao; Xin Liu; Chanjuan Peng; Liping Wang; Dong Xu
Journal:  World J Surg Oncol       Date:  2021-10-01       Impact factor: 2.754

7.  Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy.

Authors:  Cheng-Wu Zhang; Chang-Wei Dou; Xin-Long Zhang; Xi-Qiang Liu; Dong-Shen Huang; Zhi-Ming Hu; Jie Liu
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.